{
    "clinical_study": {
        "@rank": "68708", 
        "arm_group": [
            {
                "arm_group_label": "control group", 
                "arm_group_type": "Placebo Comparator", 
                "description": "radical prostatectomy without implantation of the allogenic nerve"
            }, 
            {
                "arm_group_label": "treatment group", 
                "arm_group_type": "Active Comparator", 
                "description": "radical prostatectomy with implantation of allogenic nerve graft"
            }
        ], 
        "brief_summary": {
            "textblock": "Earlier studies were able to show that an improvement of the erectile function following a\n      non-nerve sparing radical prostatectomy could be achieved using an autologous nerve graft.\n\n      The investigators evaluate the use of the implantation of the allogenic nerve graft Avance\u00ae\n      in patients undergoing non nerve-sparing radical prostatectomy."
        }, 
        "brief_title": "Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Erectile Dysfunction Following Radical Prostatectomy", 
        "condition_browse": {
            "mesh_term": "Erectile Dysfunction"
        }, 
        "detailed_description": {
            "textblock": "In this prospective randomised and single-blind, clinical phase-IV study, 60 patients are\n      randomized into the treatment group and the control group. The follow-up is at least 24\n      months.\n\n      The inclusion criteria were localized prostate cancers cT3 and/or Gleason score \u2265 7 (a or b)\n      and/or prostate-specific antigen (PSA) \u2265 20 ng/ml and furthermore an erectile function with\n      an IIEF \u2265 21 (IIEF-5).\n\n      The operation carried out is a standardised, robot assisted laparoscopic radical\n      prostatectomy with total excision of both neurovascular bundles.\n\n      The Outcome measurement is done with the \"quality of life questionnaire before and after\n      prostate surgery\" that includes the \"International Index of Erectile Function\" (IIEF)\n      questionnaire.\n\n      The limitations are a small cohort, a short observation period and the lack of statistical\n      analysis due to a still low number of patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Localized intermediate-risk or high-risk prostate cancer cT3\n\n          -  Gleason score \u2265 7 (3+4 and/or 4+3) and/or\n\n          -  PSA \u2265 20 ng/ml\n\n          -  intact preoperative erectile function with an IIEF \u2265 21 (IIEF-5).\n\n        Exclusion Criteria:\n\n          -  IIEF < 21\n\n          -  Operations in the past 6 months which could limit the erectile function\n\n          -  Erectile dysfunction in the history or current medication for erectile dysfunction\n\n          -  Current involvement in another comparable study."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01770340", 
            "org_study_id": "KEK-ZH-NR:2010-0004/0"
        }, 
        "intervention": {
            "arm_group_label": "treatment group", 
            "description": "radical prostatectomy with implantation of allogenic nerve graft", 
            "intervention_name": "Implantation of allogenic nerve graft", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "radical prostatectomy", 
            "erectile function", 
            "nerve grafting", 
            "allogenic", 
            "prostate cancer", 
            "Allogenic nerve graft", 
            "Time required for nerve grafting"
        ], 
        "lastchanged_date": "January 21, 2013", 
        "location": {
            "contact": {
                "email": "hubert.john@ksw.ch", 
                "last_name": "Hubert John, Chefarzt", 
                "phone": "+41 52 266 2982"
            }, 
            "facility": {
                "address": {
                    "city": "Winterthur", 
                    "country": "Switzerland", 
                    "state": "Kanton Z\u00fcrich", 
                    "zip": "8401"
                }, 
                "name": "Kantonsspital Winterthur"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Nerve Grafting With an Allograft During Radical Prostatectomy - Extended Follow-up in a Prospective Randomized Trial", 
        "other_outcome": {
            "description": "How much operation-time takes the nerve implantation? The time is stopped which is required for the implantation of the nerve. Start is when the prostate was removed and was deposited in the extraction bag. Stop when the anastomosis of the nerves is stitched and the anastomosis of the urethra begins.", 
            "measure": "Documented will be the extra time required for the nerve implantation", 
            "safety_issue": "No", 
            "time_frame": "at the time of operation"
        }, 
        "overall_official": {
            "affiliation": "Kantonsspital Winterthur KSW", 
            "last_name": "Hubert John, Chefarzt", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkommission", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Erectile function score (IIEF: international index of erectile function) after non nerve sparing radical prostatectomy. To show a complete impotence in the control group and an enhancement of the initial postoperative impotence in the treatment group", 
            "measure": "Erectile function score (IIEF: international index of erectile function) after non nerve sparing radical prostatectomy", 
            "safety_issue": "No", 
            "time_frame": "24 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01770340"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Monitoring of side effects and complications in connection with the nerve-implantation.", 
            "measure": "Number of Participants with Adverse Events as a Measure of Safety and Tolerability", 
            "safety_issue": "Yes", 
            "time_frame": "24 months"
        }, 
        "source": "Kantonsspital Winterthur KSW", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kantonsspital Winterthur KSW", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}